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Bovine Respiratory Syncytial Virus Infection in McNay Farm Calves
Abstract
Clinical respiratory disease occurs almost every year in fall calves in the McNay Farm herd. Diagnostic
procedures have implicated Haemophilus somnus (H. somnus) and bovine respiratory syncyial virus (BRSV)
as the infectious agents primarily associated with this disease. Therefore, the 1995 calves were closely
monitored after weaning and during the course of a respiratory disease. Serologic evidence indicated the
involvement of the same two agents in the pathogenesis of the disease. Also, experimental evidence suggested
a role for a preexisting immediate hypersensitivity to H. somnus and the development of this type of response
to BRSV. We theorize that the pathogenesis of the clinical disease involved infection with H. somnus,
establishment of immediate hypersensitivity in the lungs, viral infection with associated pathologic lesions,
and viral exacerbation of the immediate hypersensitivity reaction with resultant clinical signs and tissue
damage.
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Summary
Clinical respiratory disease occurs almost every year in
fall calves in the McNay Farm herd.  Diagnostic
procedures have implicated Haemophilus somnus (H.
somnus) and bovine respiratory syncyial virus (BRSV)
as the infectious agents primarily associated with this
disease.  Therefore, the 1995 calves were closely
monitored after weaning and during the course of a
respiratory disease.  Serologic evidence indicated the
involvement of the same two agents in the pathogenesis
of the disease.  Also, experimental evidence suggested a
role for a preexisting immediate hypersensitivity to H.
somnus and the development of this type of response to
BRSV.  We theorize that the pathogenesis of the clinical
disease involved infection with H. somnus, establishment
of immediate hypersensitivity in the lungs, viral infection
with associated pathologic lesions, and viral
exacerbation of the immediate hypersensitivity reaction
with resultant clinical signs and tissue damage.
Introduction
Calves in the McNay Farm herd have been monitored
for respiratory disease for several years by observation of
clinical signs, necropsies and serologic methods.  Widely
recognized pathogens including bovine respiratory syncytial
virus (BRSV), infectious bovine rhinotracheitis virus,
parainfluenza type 3 virus, adenovirus type 3, bovine viral
diarrhea virus, Haemophilus somnus (H. somnus),
Pasteurella haemolytica (P. haemolytica) and Pasteurella
multocida are present in this herd.  The most serious
respiratory disease problem has been in fall calves that
annually break with clinical disease in December or early
January at 90 to 130 days of age.  Morbidity is high but
mortality has been reduced from 20% several years ago to 0
to 5% in recent years due in part to improved management
practices.  Haemophilus somnus was a major contributor to
mortality in the 1980s but in recent years, although the
organism is still present in the herd, has not induced the
severe bacterial pneumonia with associated mortality.
Rather, the clinical disease is an acute pneumonia with the
involvement of H. somnus and BRSV.
These fall calves acquire appreciable levels of maternal
antibodies from their dams that apparently protect the calves
from BRSV infection during the neonatal period.  Previous
attempts to immunize calves in October or November with
commercial modified-live (MLV) BRSV vaccine have not
prevented clinical disease.  Maternal antibodies are at a level
that apparently blocks an active immune response to the
vaccine.  We report observations on 1995 fall calves that
developed an acute episode of respiratory disease shortly
after vaccination with a modified live BRSV vaccine.  A
group of these calves had received a primary dose of an
experimental BRSV subunit vaccine.
Materials and Methods
Eighty-seven calves were weaned on November 15,
1995, and randomly distributed into four pens.  Pens one
and two as well as three and four were separated only by a
fence, but there was a 12-foot wide alley between the two
pen units.  On November 21 all calves were bled for serum,
and 20 calves (10 each in pens one and two) were
administered an experimental BRSV subunit vaccine.  On
December 6 calves in pens one, two and three were bled and
calves in pens one and two administered a two ml dose of a
commercial modified-live BRSV vaccine.  At this time a dry
cough was noted among calves in all pens.
Our previous experience with fall calves suggested that
clinical observation should be supplemented with other
determinations including skin testing and serology.
Therefore, sequential blood samples were collected and
serum was stored at –20oC.  Serologic tests included virus
neutralization tests for BRSV antibody and ELISA for
antibodies to P. haemolytica and H. somnus.  The ELISA
procedure for IgG antibodies utilized a peroxidase-labeled
anti-bovine IgG secondary antibody.  The ELISA procedure
for IgE antibodies utilized a mouse monoclonal anti-bovine
IgE antibody preparation and peroxidase labeled anti-mouse
IgG.  Two positive and negative sera were included in each
microtiter plate at the same dilutions as the test sera.  This
permitted calculations and reporting of the level of
antibodies as a percentage of the standard:
   Percentage     =        O.D. Test – O.D. Negative
   of Standard              O.D. Standard – O.D. Negative
Skin tests were conducted by the injection of 100µl of
antigen intradermally on the inside of the thigh.  The H.
somnus antigen was supernatant from washed H. somnus
organisms passed through a French press and centrifuged for
30 minutes at 5000g.  The BRSV antigen was culture
supernatant from BRSV infected bovine lung cells.  The
antigen preparation was heated at 56oC for 30 minutes to
inactivate the virus.   The experimental protocol was as
follows:
11/15/95 Calves Weaned
11/21/95 Calves Bled
Vaccinated 20 Calves -- Pens 1 and 2
12/06/95 Calves Bled -- Pens 1, 2, and 3
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Vaccinated (MLV Vaccine) Pens 1 and 2
12/12/95 Calves Bled -- Pens 1 and 2
Skin Tested 4 Calves -- H. somnus
12/13/95 Sick Calves -- Pen 4
Temperatured Calves -- Pens 3 and 4
Switched Calves -- Pens 2 and 3
12/14/95 One Calf Dead -- Pen 4
Temperatured Calves -- Pens 1, 2, and 3
12/15/95 Bled Calves -- Pens 1 and 2
Temperatured Calves -- Pens 1, 2, and 3
Skin Tested 6 Calves -- BRSV and H.
somnus
Nasal Swabs -- 10 Calves
Second Calf Dead
12/16/95 Temperatured Calves -- Pens 1, 2, and 3
12/18/95 Temperatured Calves -- Pens 1, 2, and 3
12/20/95 Bled Calves -- Pens 1, 2, and 3
01/10/96 Bled Calves -- All Pens
Observations
Signs of clinical respiratory disease appeared in calves
in pen four (nonvaccinated) on December 13 (high
temperatures, depression and labored breathing).  At this
time many calves in pen three had an increased rectal
temperature but did not show clinical signs.  On December
14 overt clinical disease was observed in calves in all pens,
and many calves had increased rectal temperatures up to
106.1°F.  One calf in pen four died and necropsy revealed
extensive consolidation and emphysema in the lungs.
Microscopically, there was severe proliferative and
necrotizing interstitial pneumonia and bronchiolitis.  There
was also moderate suppurative bronchopneumonia.
Presence of BRSV was demonstrated by direct fluorescent
antibody procedures, but no bacteria were isolated from lung
tissue.  A second calf died on December 15, and necropsy
revealed similar lesions in the lungs.  Many calves were
treated with antihistamines and antibiotics, and the
remaining calves returned to normal by December 20.
Interest in immediate hypersensitivity as a contributor to
respiratory disease led us to skin test four animals on
December 12.  Three of these animals had positive reactions
to H. somnus antigen.  Skin tests on six animals on
December 15 were positive for both H. somnus and BRSV
antigens.  Two of these animals developed systemic
anaphylactic shock within 10-15 minutes, were treated with
epinephrine and antihistamine, and recovered.
Serologic tests served to confirm the involvement of
infectious agents in this disease.  Neutralizing antibody titers
for BRSV were variable among calves at the start of the
experiment with most calves possessing moderate titers
(probably of maternal origin).  The titers of BRSV
antibodies increased in most calves by December 20 (Table
1), but the increase was moderate and titers were declining
by January 10.  Antibody titers of animals given the
experimental vaccine were not different from the controls.
Also the vaccine did not protect the calves from clinical
disease although disease appeared to be less severe, and no
death losses occurred in that group.  Serum antibody levels
to H. somnus of a few calves prior to the outbreak of clinical
disease are provided in Table 2.  Levels of IgG class
antibodies were moderate and did not increase during the
period of observation.  However, appreciable levels of IgE
class antibodies were present in the serum of these calves
prior to the development of clinical disease.  Calves had low
titers of antibodies to P. haemolytica at the start with a
marked increase by December 20 (data not included).
Table 1.  BRSV antibody titers of selected calves.
       Date
Calf No. 11/21 12/6 12/15 12/20
000 16 8 8 256
002 128 64 64 128
006 16 8 4 16
178 32 16 8 256
180 32 32 16 16
194 16 4 4 64
326 2 4 32 256
Table 2.  Haemophilus somnus antibody levels in selected
calves.
Date
         11/21       11/29    12/6
Calf No. IgG IgE IgG IgE IgG IgE
000 16.3* 63.3 7.8 39.8 9.4 42.7
002 16.8 54.5 7.8 44.2 3.8 38.0
006 15.7 40.2 7.7 33.8 6.1 43.4
008 20.5 9.0 18.3 10.5 6.8 19.9
010 15.4 64.8 15.8 57.1 16.6 60.0
*Percentage of standard
Conclusions
Clinical respiratory disease caused by infection with
BRSV developed in calves that had residual maternal
antibodies.  This was particularly interesting because even a
low level of maternal antibodies precludes successful
immunization with modified-live BRSV vaccine.
Consequently, immunization of calves against BRSV prior
to natural exposure to the virus remains a major problem.  A
particularly important finding of this experimentation comes
from the clinical and laboratory observations.  Many of the
calves were apparently infected with H. somnus and had
developed appreciable levels of circulating IgE class
antibodies to that organism.  This is consistent with the
positive skin test reactions induced in the calves.  These
finding are supportive for the presence of an immediate type
of hypersensitivity in these calves.  This preexisting
hypersensitivity probably contributed to the severity of the
clinical disease.  Although BRSV infection can induce the
production of IgE class antibodies and an immediate
hypersensitivity, the preexisting hypersensitive state
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probably enhanced the response.  The severity of the clinical
disease may result from the combination of viral infection
and products of the immediate hypersensitivity reaction.
Viral infection and Type I interferon have been reported to
accentuate release of mediators of allergic reactions, and
BRSV may have this capability.  Therefore, it is reasonable
to conclude that expression of clinical disease resulted not
only from cell destruction by the virus but an immediate
hypersensitivity reaction in the lungs.
The failure of the experimental vaccine to protect the
calves could have been expected under the circumstances.
The vaccine is a subunit intended only to prime the animal
for secondary responses to the virus.  The secondary
response would be induced by the second vaccination with
the whole virus commercial vaccine.  However, natural
infection with wild strain, virulent virus interceded shortly
after the booster vaccination.  Thus, there was inadequate
time for development of protective immunity.
Acknowledgments
The investigators appreciate the contribution of the
mouse monoclonal anti-bovine IgE antibody preparation by
Dr. Laurel Gershwin, College of Veterinary Medicine,
University of California-Davis.
This research was supported in part by funds provided
through the Iowa Livestock Health Advisory Council.
